Canadian Cannabis LP
Tier 2 Index
The Canadian Cannabis LP Tier 2 Index represents the publicly-traded market for companies that are currently generating quarterly sales of less than C$4 million.
|ABCN:CA||Abcann Global Corporation|
|EMH:CA||Emerald Health Therapeutics Inc.|
|FIRE:CA||Supreme Cannabis Inc|
|HVT:CA||Harvest One Cannabis Inc.|
|IMH:CA||Invictus MD Strategies|
|MARI:CNX||Maricann Group Inc.|
|MJN:CA||Cronos Group Inc.|
|NINE:CA||Delta 9 Cannabis Inc.|
|OGI:CA||OrganiGram Holdings Inc|
|THCX:CA||The Hydropothecary Corporation|
The Canadian Cannabis LP Tier 2 index is equal-weighted at the time of the month-end rebalancing and includes companies licensed to cultivate and to sell but with quarterly revenue below $4 million.
Inclusion in the index is not an endorsement or recommendation of any company. The companies included are designed to represent the overall market for the medical and legal marijuana sector. To summarize, it includes both the good and the bad. This Site is not an intermediary, broker/dealer, investment advisor, or exchange and does not provide investment advice or investment advisory services. Market Data © 2018 QuoteMedia. Data delayed 15 minutes unless otherwise indicated.
Visit and bookmark the data-driven, fact-based Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures to keep track of the cannabis stocks that generate industry sales of more than $2.5m per quarter.
Compare the index returns to Alan Brochstein's 420 Opportunity model portfolio on publicly-traded stock due diligence platform, 420Investor.com.
Discover the best strategies to capitalize on the Green Rush!